XML 39 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Equity
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Equity Equity
Accumulated other comprehensive income (loss)
Summarized below is the roll forward of AOCI, net of tax.
Years Ended December 31,
In millions202220212020
Foreign currency translation
Beginning balance$18.4 $16.4 $1.5 
Net gains (losses) on foreign currency translation(74.9)(5.3)23.9 
Gains (losses) on net investment hedges13.9 9.6 (11.7)
Less: tax provision (benefit)3.2 2.3 (2.7)
Net gains (losses) on net investment hedges10.7 7.3 (9.0)
Other comprehensive income (loss), net of tax(64.2)2.0 14.9 
Ending balance$(45.8)$18.4 $16.4 
Derivative instruments
Beginning balance$(2.1)$(6.9)$(3.5)
Gains (losses) on derivative instruments11.1 7.2 (5.6)
Less: tax provision (benefit)2.6 1.7 (1.3)
Net gains (losses) on derivative instruments8.5 5.5 (4.3)
(Gains) losses reclassified to net income(10.2)(1.0)1.2 
Less: tax (provision) benefit(2.4)(0.3)0.3 
Net (gains) losses reclassified to net income(7.8)(0.7)0.9 
Other comprehensive income (loss), net of tax0.7 4.8 (3.4)
Ending balance$(1.4)$(2.1)$(6.9)
Pension and other postretirement benefits
Beginning balance$(3.2)$(4.8)$(3.0)
Unrealized actuarial gains (losses) and prior service (costs) credits4.4 1.9 (2.7)
Less: tax provision (benefit)1.0 0.4 (0.6)
Net actuarial gains (losses) and prior service (costs) credits3.4 1.5 (2.1)
Amortization of actuarial and other (gains) losses, prior service cost (credits), and settlement and curtailment (income) charge reclassified to net income0.3 0.2 0.3 
Less: tax (provision) benefit0.1 0.1 — 
Net actuarial and other (gains) losses, amortization of prior service cost (credits), and settlement and curtailment (income) charge reclassified to net income0.2 0.1 0.3 
Other comprehensive income (loss), net of tax3.6 1.6 (1.8)
Ending balance$0.4 $(3.2)$(4.8)
Total AOCI ending balance at December 31$(46.8)$13.1 $4.7 
Reclassifications of accumulated other comprehensive income (loss)
The table below provides details about the reclassifications from AOCI and the affected line items on the consolidated statement of operations for each of the periods presented.
Years Ended December 31,
In millions202220212020
Derivative Instruments
Currency exchange contracts (1)
$2.0 $0.3 $(0.1)
Natural gas contracts (2)
6.5 0.7 (1.1)
Interest rate swaps (4)
1.7 — — 
Total before tax10.2 1.0 (1.2)
(Provision) benefit for income taxes(2.4)(0.3)0.3 
Amount included within net income (loss)$7.8 $0.7 $(0.9)
Pension and other postretirement benefits
Amortization of prior service credit (costs) (2)
$(0.1)$(0.1)$(0.1)
Amortization of unrecognized net actuarial and other gains (losses) (3)
— (0.1)(0.1)
Recognized gain (loss) due to curtailment and settlement (2)
(0.2)— (0.1)
Total before tax(0.3)(0.2)(0.3)
(Provision) benefit for income taxes0.1 0.1 — 
Amount included within net income (loss)$(0.2)$(0.1)$(0.3)
_______________
(1) Included within "Net sales" on the consolidated statements of operations.
(2) Included within "Cost of sales" on the consolidated statements of operations.
(3) Included within "Other (income) expense, net" on the consolidated statements of operations.
(4) Included within "Interest income" on the consolidated statements of operations.
Share Repurchases
On July 25, 2022, our Board of Directors authorized the repurchase of up to $500.0 million of our common stock (the "2022 Authorization"), and rescinded the prior outstanding repurchase authorization with respect to the shares that remained unused under the prior authorization. Shares under the current repurchase authorization may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market prevailing conditions and other factors, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
During the year ended December 31, 2022, we repurchased $145.2 million in common stock, representing 2,112,463 shares of our common stock at a weighted average cost per share of $68.73. At December 31, 2022, $444.7 million remained unused under our Board-authorized repurchase program. During the year ended December 31, 2021 and 2020, we repurchased $109.4 million and $88.0 million in common stock, representing 1,421,379 and 1,533,442 shares of our common stock at a weighted average cost per share of $76.98 and $57.38, respectively.